Metasphere Labs Inc.
LABZ
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -108.36% | -102.17% | -99.89% | -99.93% | -90.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -108.36% | -102.17% | -99.89% | -99.93% | -90.27% |
| Cost of Revenue | -134.07% | -110.45% | -99.36% | -99.54% | -85.65% |
| Gross Profit | -100.60% | -100.15% | -99.99% | -99.99% | -91.11% |
| SG&A Expenses | -54.27% | -45.47% | -43.59% | -27.01% | -15.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -62.11% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -58.98% | -57.52% | -57.21% | -47.64% | -32.53% |
| Operating Income | 45.63% | -23.88% | -1,174.48% | -221.65% | -211.85% |
| Income Before Tax | 64.04% | 43.25% | -17.84% | -31,109.52% | -347.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 64.04% | 43.25% | -17.84% | -31,109.52% | -347.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.04% | 43.25% | -17.84% | -31,109.52% | -405.11% |
| EBIT | 45.63% | -23.88% | -1,174.48% | -221.65% | -211.85% |
| EBITDA | 77.27% | 3.75% | -536.58% | -206.16% | -193.94% |
| EPS Basic | 73.41% | 57.21% | -182.95% | -114.77% | 89.00% |
| Normalized Basic EPS | 57.92% | 20.06% | -284.00% | -113.06% | -160.91% |
| EPS Diluted | 73.41% | 58.77% | 1.39% | -115.95% | 89.30% |
| Normalized Diluted EPS | 57.92% | 23.50% | -420.75% | -114.05% | -182.05% |
| Average Basic Shares Outstanding | 27.46% | 13.06% | 33.53% | 79.03% | 143.85% |
| Average Diluted Shares Outstanding | 27.46% | 1.97% | 8.26% | 35.18% | 65.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |